Cohort Study on the Effect of a Combined Treatment of Traditional Chinese Medicine and Western Medicine on the Relapse and Metastasis of 222 Patients with Stage Ⅱ and Ⅲ Colorectal Cancer after Radical Operation

Objective:To evaluate the effectiveness of a comprehensive therapy of traditional Chinese medicine(TCM)in reducing the relapse and metastasis of stageⅡandⅢcolorectal cancer based on conventional Western medicine(WM)therapy.Methods:Two hundred and twenty-two patients in total, diagnosed as stageⅡandⅢcolorectal cancer from February 2000 to March 2006,were recruited from Xiyuan Hospital,China Academy of Chinese Medical Sciences and the General Hospital of Beijing Military Area.They were followed-up once every 3-6 months.Twenty cases dropped out from the cohort.The remaining 202 patients were all treated with routine WM treatment [including R0 radical operation,or chemotherapy or/and radiotherapy according to national comprehensive cancer network(NCCN)clinical guidelines].These patients were assigned to two groups based on whether or not they were additionally treated with TCM comprehensive therapy(orally administered with a decoction according to syndrome differentiation,combined with a traditional patent drug over one year).Ninety-eight patients from Xiyuan Hospital were treated with WM and TCM(combined group),and 104 patients from the General Hospital of Beijing Military Area were treated with WM alone(WM group).The demographic data at baseline were comparable,including the operation times,age,sex,TNM staging,and pathological types.The patients were followed-up for one to five years.Up to now,there are 98,98,77,64,and 47 patients with 1,2,3, 4,and 5 years of follow-up in the combined group,respectively;and 104,104,97,81,and 55 patients in the WM group,respectively.The results of the 5-year follow-up of all the patients will be available in 2011. Results:The relapse/metastasis rate of 1-,2-,3-,4-,and 5-year were 0(0/98),2.04%(2/98),11.69% (9/77),14.06%(9/64),and 21.28%,(10/47)in the combined group,and were 4.80%(5/104),16.35% (17/104),21.65%(21/97),25.93%(21/81),and 38.18%(21/55)in the WM group,respectively.A significant difference was found in the second year between the two groups(χ~2=12.117,P = 0.000).Median relapse/ metastasis time was 26.5 months in the combined group and 16.0 months in the WM group.Conclusion: The combined therapy of TCM and WM may have great clinical value and a potential for decreasing the relapse or metastasis rate in stageⅡandⅢcolorectal cancer after conventional WM therapy.     

Effect of Jieze No.1 (洁泽 号) on cervicitis caused by ureaplasma urealyticum and on ureaplasma urealyticum in vitro

Objective： To observe the clinical therapeutic effect of Jieze No. 1 （洁泽Ⅰ号） on cervicitis caused by ureaplasma urealyticum and its inhibitory effect on ureaplasma urealyticum （Uu） in vitro. Methods： A total of 393 patients suffering from cervicitis induced by ureaplasma urealyticum without other complications were randomly assigned to 3 groups, the combined treatment group： 140 patients treated with Chinese herbs Jieze No.1 by vaginal lavage, 30 min each time, once a clay for 10 consecutive clays and oral administration of Azithromycin, 1.0 g once every 72 h for three times; Jieze group： 115 patients were treated with Jieze No.1 alone by vaginal lavage, 30 min each time, once a day for 10 consecutive days; and the Azithromycin group： 138 patients were treated with oral administration of Azithromycin, 1.0 g once in 72 h for three times. All the patients were treated for 1 therapeutic course and condom were used for contraception during the treatment course. The Uu patients were examined again after 21 clays of treatment. The therapeutic effect on cervicitis was observed. The experimental study of Jieze No. 1 on the Uu strain separated from the secretion of the urogenital tract was also observed. The minimum inhibitory concentration （MIC） and minimum bactericidal concentration （MBC） of the Uu were investigated. Results： The total effective rate of the combined group was 85.3%, showing a significant difference compared with the Jieze group （67.8%） and the Azithromycin group （60.3%, both P〈0.01）. There was no statistical significance between the latter two groups （P〉0.05）. The clearing rate of Uu in the combined group was 78.4%, that of the Jieze group was 60.9% and the Azithromycin group was 47.9%. The combined group also showed a significant difference in comparison with the other two groups （all P〈0.01）. Especially for the drugresistant strain, the clearing rate of Uu reached 48.1% in the combined group, 42.1% in the Jieze group, and 16.1% in the Azithromyc     

Effect of TCM Combined with Chemotherapy on Immune Function and Quality of Life of Patients with Non-small Cell Lung Cancer inStage Ⅲ-Ⅳ

Objective: To observe and compare the effect of traditional Chinese medicine (TCM) combined with chemotherapy (CT) on immune function and quality of life (QOL)of patients with non-small cell lung cancer (NSCLC) in stage Ⅲ-Ⅳ. Methods: One hundred cases with stage Ⅲ-Ⅳ NSCLC were randomly divided into two groups. The treated group (n=50) received CT combined with TCM, and the control group received CT alone. The percentage of T lymphocyte subset in peripheral blood and the change of natural killer (NK) cell count were observed after treatment. The QOL and tolerance of CT were also compared between the two groups after treatment. Results: In the treated group, CD3 cell count, CD4 cell count, CD4/ CDg ratio and NK cell activity were higher than those in control group, while CD8 cell count in the treated group was lower than that in the control group (P<0.05), and QOL and tolerance of CT in the treated group were also better (P<0.05). Conclusion: TCM combined with CT could raise the patients' ability in to     

Clinical observation on the efficacy of Xiaoshui decoction (消水方) combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion

Objective： To observe the clinical efficacy of Xiaoshui decoction （XSD,消水方） combined with intrapleural perfusion of cisplatin in the treatment of malignant pleural effusion. Methods： Fifty-one patients with malignant pleural effusion were randomly assigned to two groups. The treated group patients） received oral administration of XSD combined with intrapleural perfusion of cisplatin, and control group （25 patients） was only treated with intrapleural perfusion of cisplatin. The effects of 26 he he short-term efficacy, quality of life scores and clinical symptom scores of malignant pleural effusion were evaluated. Results： The short-term efficacy in the treated group and the control group was 72.0% and 58.3%, respectively, and no significant difference was found （P〉0.05）. In contrast, the quality of life in the treated group was significantly improved compared to that of the control group （P〈0.05）, and so was the symptom remission （P〈0.05）. Conclusions： The combined therapy of XSD and intrapleural perfusion of cisplatin did not show obvious improvement in short-term efficacy, but the therapy remarkably alleviated the symptoms and improved the quality of life of patients.     

Two-year Observation of the Clinical Efficacy in Treating Chronic Hepatitis B Patients with Ganxian Recipe(肝纤方) and Lamivudinene

Objective:To evaluate the clinical efficacy of Ganxian recipe (肝纤方, GXR) and lamivudine (LVD) in a two-year treatment of chronic hepatitis B (CHB). Methods: One hundred and twenty patients with CHB were randomly divided into the combinedly treated group (combined group) of 40 CHB patients who were treated with GXR combined with LVD. Another 40 CHB patients were treated with LVD alone (WM group), and still another 40 CHB patients were treated with GXR alone (TCM group). All these cases were randomly controlled and observed for two years. Results: Comprehensive efficacy: Total effective rate of the combined group (complete response and partial response) was 92. 5 %, while that of the WM group was 67.5 % and TCM group 57.5 %, respectively, with the difference between them was significant (P＜0.01);after treatment, the hepatic functions (AST, ALT, SB) of the three groups were all reduced, and the reduction in the combined group was particularly significant in comparison with the WM group or TCM group, P＜0.05 or P＜0.01 respectively, suggesting that the effect in the combined group was better than that in the other two groups; the rate of tyrosine-methionine-aspartate-aspartate (YMDD) virus mutation: it was 7.5%in the combined group, 40.0% in the WM group, and 5.0% in the TCM group; liver fibrosis improvement parameter: after treatment, the results in the combined group got better than those in the other two groups.Conclusion: GXR could inhibit the appearance of YMDD after long-term application of LVD, and combined use has marked synergism.     

Clinical Observation on Treatment of Acute Myelocytic Leukemia by Supplementing Qi, Nourishing Yin and Clearing Heat Principle

Objective: To observe the clinical efficacy of TCM with supplementing Qi, nourishing Yin and clearing heat principle (SQNYCH) combined with chemotherapy in treating myelocytic leukemia. Methods: One hundred and fourteen patients were randomly divided into the treated group (n= 68) and the control group (n= 46). To the treated group, SQNYCH was applied as the basic treatment, with combined chemotherapeutic protocol, using DA, HA and IA, to induce remission, and to the M3 patients, all-trans retinoic acid and arsenic trioxide were given. As for patients in the control group, only western medicine was administered. Results: In the treated group 49 patients (72.1%) were completely remitted, 9 (13.2%) partially remitted and the total remission rate being85. 3% , which was significantly different from that in the control group. After treatment, the blood and bone marrow picture were obviously improved in both groups, but the increase of hemoglobin and platelet were better in the treated group than those in the     

A Randomized Trial of Chinese Medicine Lirukang Granule (利乳康颗粒) Combined with Psychological Intervention for Cyclomastopathy and Menoxenia

Objective:To observe the influence of therapy with Chinese medicine Lirukang Granule（利乳康颗粒）,LRKG) combined with psychological intervention on anxiety states and sex hormones in patients with cyclomastopathy and menoxenia.Methods:A total of 470 subjects were randomly assigned to three groups by the net-central randomization system,the treatment group（161 patients,treated with LRKG and psychological intervention）,the Chinese medicine group（157 patients,treated with LRKG）,and the psychological intervention group（152 patients,treated with psychological intervention）.The dose of LRKG was 12 g three times per day; psychological intervention included establishing relations,cognitive intervention and psychological persuasion, 30-40 min per session,once a week.The therapy duration for all groups was three months.The efficacy was compared and anxiety state/State-Trait Anxiety Invertory（STAI） scoring was measured before and after treatment.The serum estradiol（E₂）,progesterone（P）,prolactin（PRL） and follicle stimulating hormone（FSH） levels of 60 patients selected randomly from each group during the luteal phase were measured before and after treatment,and a group of 20 healthy women were evaluated for comparison.A follow-up was arranged for one year after treatment.Results:Thirty subjects were lost to follow-up.（1） Comparison of efficacy:the markedly effective rate and the total effective rate of the treatment group were 86.67%（131/150） and 98.00%（147/150）, respectively;of the Chinese medicine group,64.58%（93/144） and 90.27%（130/144）,respectively;and of the psychological intervention group,0%（0/146） and 3.42%（5/146）,respectively.The markedly effective rate and the total effective rate in the treatment group were significantly higher than those in the Chinese medicine and psychological intervention groups（P<0.05）.（2） Comparison of STAI scoring:STAI scoring was decreased dramatically in the treatment group after treatment compared with that of the Chinese medicine group（P<0.01）, but there was no significant difference compared with the psychological intervention group.（3） Comparison of levels of sex hormones:E₂,P,PRL and FSH of the three patient groups were disordered before treatment,and significantly different from healthy women（P<0.01）.After treatment,the levels of P and FSH of the treatment group were significantly increased（P<0.01）,E₂ and PRL were significantly reduced,which were also significantly decreased compared with the psychological intervention groups（P<0.01）.（4） Follow-up:the markedly effective rate and the total effective rate of the treatment group remained higher than those of the other two groups after one year of treatment（P<0.05）.（5） Adverse reactions:no obvious adverse reactions were found among the three groups.Conclusions:Therapy with Chinese medicine combined with psychological intervention was effective for short-term and long-term treatment of cyclomastopathy and menoxenia.The mechanism might be related to the regulation of sex hormones.     

Clinical Observation on Effect of Combination of Zhuanyindan (转阴丹) and Hormone in Treating MaleInfertility with Positive Antisperm Antibody

Objective:To explore the therapeutic effect of combination of Zhuanyindan (ZYD, 转阴丹, a self-made Chinese herbal preparation) and hormone in treating male infertility with positive antisperm antibody and its influence on nitric oxide (NO) level. Methods:Eighty-two patients were randomly divided (according to the digital list) into the WM group (n = 20, treated with prednisone), the TCM group (n=28, treated with ZYD) and the ICWM group (n=34, treated with prednisone plus ZYD). The clinical effect, negative converting rate of antisperm antibody, changes of NO level in semen and various parameters of sperm motion before and after treatment were observed. Results: The total effective rate in the ICWM group was 88.2%, that in theTCM group 75. 0% and in the WM group 65. 0%. Significant difference was seen in the ICWM and TCM group before and after treatment in NO level, sperm motion parameters, including linear motion speed, linearity, propulsion, whip frequency, sperm vitality and mean moving angle, and qu     

Comparative Study on the Efficacy of Yiweining （异位宁） and Gestrinone for Post-operational Treatment of

Objective： To observe the clinical efficacy and safety of Yiweining （异位宁, YWN） and gestrinone （GT） in treating post-operational patients of stage Ⅲ endometriosis （EM-Ⅲ）. Methods： Fifty-two patients of EM-Ⅲ after operation were randomly assigned into three groups, the YWN group （20 patients） was treated through oral intake of YWN 200 ml, twice a day; the GT group （19 patients） treated with gestrinone 2.5 mg, twice every week, with the medication starting from the 7th post-operational day and lasting for 6 months. The control group （13 patients） was untreated. Six months was one therapeutic course, and follow-up study was carried out in the 6-30 months after the end of the medication. Results： The recurrence rate in the YWN group and the GT group were 5.0% and 5.3% respectively, showing insignificant difference between the two groups, but they were lower than that in the control group （30.7%, P〈0.05）. Besides, the adverse reaction rate in the YWN group was lower than that in the GT group （ 10.0% vs 31.6%, P〈 0.05）. Conclusion： Application of YWN to prevent the post-operational recurrence of endometriosis is effective and safe, and its efficacy is similar to that of GT.     

Clinical Study on Preventing and Treating Left Ventricle Remodeling after Acute Myocardial Infarction with Integrative Chinese and Western Medicine

Objective: To explore the clinical efficacy of Xuefu Zhuyu (血府逐瘀, XFZY) oral liquid combined with western medicine (WM) in reversing left ventricle remodeling (LVR) after acute myocardial infarction (AMI) in patients and its therapeutic mechanism. Methods: Sixty patients conforming to criteria were divided into the treated group and WM control group with randomly stratified method. Thirty cases were assigned to each group, they were given XFZY WM general treatment and WM general treatment respectively. Color Doppler ultrasonography was used to study the changes of LVR before and after treatment.Results: In both groups, before and after treatment the P value of such parameters as the changes of their left diastolic volume (LDV), left systolic volume (LSV), left ventricle ejection fraction (EF) was ＜0. 05, suggesting that the difference of various parameters was significantly different; but when compared with the results of the 12th week after medications, the change of LDV, LSV, EF showed that the LDV, LSV of the treated group were lower than that of the control group, the EF of the treated group was higher than that of the control group, and the P value of various groups was all ＜0. 05, suggesting that the different data of various groups showed significant difference. Conclusion: Conventional WM treatment and XFZY combined with WM could both, in treating AMI, effectively reverse the patients′ LVR; yet the use of integrative Chinese and western medicine on reversing patients LVR showed even better results than that of simple WM treatment.     

Study on Treatment of Polycystic Ovarian Syndrome with Infertility by Combined Therapy of Chinese Herbal Medicine and Compound Cyproterone Acetate

Objective: To evaluate the effect of combined therapy of Chinese herbal medicine and compound cyproterone acetate (CPA) in treating non-obesity polycystic ovarian syndrome (PCOS) and to explore its mechanism in improving withdrawal ovulation. Methods: Eighty-six patients of non-obesity P-COS, typed as Shen-deficiency with blood stasis Syndrome or Shen-deficiency with Phlegm-Dampness Syndrome by Syndrome Differentiation in traditional Chines medicine, were randomly divided into three groups: (1) The TCM group (n = 26) was treated with Chinese drugs for 6 menstrual cycles; (2) The western medicine (WM) group (n=30) was treated with 1 tablet of CPA for 21 days, with the treatment beginning from the 5th day of menstruation. The treatment was given for 3 menstrual cycles by repetitious medication, which stopped and restarted on the 5th day of withdrawal bleeding. Then the ovulation promoting therapy was applied by using clomifene citrate and human chorionic gonadotropin (CC/hCG) for 3 menstrual cycles; (3) T     

中医及中西医结合治疗老年单纯收缩期高血压的多中心随机双盲对照临床试验

背景：单纯收缩期高血压（isolated systolic hypertension,ISH）是老年人的常见病,严重危害老年人的健康。中医及中西医结合治疗模式在改善老年ISH患者生活质量以及保护靶器官等方面具有一定优势,但需要进一步的循证医学研究。目的：观察中医（降压胶囊）及中西医结合（降压胶囊联合尼莫地平）治疗模式对老年ISH患者血压、血管活性物质的影响及其安全性。设计、场所、受试者和干预措施：采用多中心、随机双盲、阳性对照的试验设计。按标准入选中国中医科学院西苑医院、北京延庆县中医院及延庆社区卫生服务中心的老年ISH患者270例,采用随机区组法分为中医组（降压胶囊联合尼莫地平模拟药）、中西医结合组（降压胶囊联合尼莫地平）和西医组（尼莫地平联合降压胶囊模拟药）,每组各90例。疗程为4周。主要结局指标：观察各组治疗后诊室血压和动态血压水平,血管活性物质如内皮素-1（endothelin-1,ET-1）、一氧化氮（nitric oxide,NO）、血栓素B_2（thromboxane B_2,TXB_2）和6-酮-前列腺素1α（6-ketoprostaglandin1α,6-keto-PGF1α）水平的变化,并评价其安全性。结果：治疗结束后,中医组脱落10例（80例完成试验）,中西医结合组脱落14例（76例完成试验）,西医组脱落5例（85例完成试验）。治疗后各组收缩期血压值低于治疗前,差异均有统计学意义（P〈0.05）,中西医结合组收缩期血压明显低于中医组或西医组（P〈0.05）。治疗后各组24 h平均收缩压及昼间平均收缩压明显降低,中西医结合组夜间平均收缩压亦明显降低,与治疗前比较,差异有统计学意义（P〈0.05）;中西医结合组24 h平均收缩压和昼间平均收缩压低于中医组和西医组（P〈0.05）。治疗后各组患者血清NO、血浆6-keto-PGF1α水平均升高,而血浆ET-1和TXB_2水平降低（P〈0.05）,且中西医结合疗法对降低血浆TXB_2含量的作用明显优于中医或西医疗法（P〈0.05）。结论：中医及中西医结合治疗模式应用于老年ISH患者的疗效肯定,安全性高,且中西医结合治疗模式在降压及相关指标改善等方面具有明显协同增效的优势,值得进一步研究。     

中西医结合治疗卵巢功能低下性不孕症的临床疗效

 目的 观察中西医结合治疗卵巢功能低下性不孕症患者的临床疗效。方法 收集2016年2月至2017年12月在复旦大学附属妇产科医院就诊的不孕症患者,根据纳入标准筛选出符合条件的卵巢功能低下性不孕症患者316例,根据治疗方法不同分为3组：中药治疗（TCM）组（n=115）、西药治疗（WM）组（n=50）和中西医结合治疗（ITCWM）组（n=151）。3组均连续治疗6个月经周期,疗程结束后观察3组患者治疗前后中医证候积分、基础血清卵泡刺激素（follicule-stimulating hormone,FSH）、黄体生成素（luteinizing hormone,LH）、FSH/LH、雌二醇（estradiol,E₂）、睾酮（testosterone,T）水平的改变,并统计3组患者治疗后的成功妊娠率。结果 3组患者治疗前年龄、中医证候积分、基础血清FSH、LH、FSH/LH、T、E₂水平差异均无统计学意义。3组患者治疗后中医证候积分、血清FSH水平、FSH/LH均显著低于治疗前（P<0.05）,血清T水平显著高于治疗前（P<0.05）。3组患者治疗后组间比较,ITCWM组中医证候治疗总有效率明显高于TCM组、WM组（P<0.05）;ITCWM组血清FSH、FSH/LH水平下降较TCM组、WM组明显（P<0.05）;血清T、E₂水平上升较TCM组、WM组明显（P<0.05）;ITCWM组成功妊娠率明显高于TCM组及WM组（P<0.05）。结论 中西医结合治疗卵巢功能低下性不孕症疗效明显。血清T水平可以在一定程度上反映卵巢功能,可以作为评价卵巢功能的一个重要指标。     

General survey of traditional Chinese medicine and Western medicine researches on tumor metastasis

Aggression and metastasis of tumor cells is themost essential characteristic of malignant tumor's bi-ological behavior , which is the result of a series ofcomplicated and multi-stepped mutual actions be-tween tumor cells and host(1).Clinically , metastasisand recurrence are one of the causes of death oftumor patient . Therefore, pathogenetic mechanismof tumor metastasis andits prevention andtreat mentis the key point of traditional Chinese medicine(TCM) and Western medicine ( WM) in studying…     

灯盏花注射液与依那普利联合治疗非胰岛素依赖型糖尿病肾病临床研究

目的 :探讨中西医结合治疗糖尿病肾病临床疗效。方法 :观测纯中药制剂灯盏花注射液和西药依那普利组成的中西医结合疗法 (治疗组 )与单纯西药依那普利 (对照组 )治疗非胰岛素依赖型糖尿病肾病患者治疗前后 2 4h尿蛋白定量、血尿素氮、肌酐、平均动脉压、血脂、血液流变学指标变化。结果 :治疗 4wk后治疗组与对照组 2 4h尿蛋白定量、血尿素氮、肌酐比较差别显著 (p <0 0 5 ,p <0 0 1) ,平均动脉压两组治疗后 ,差别无显著性 (p >0 0 5 ) ,而治疗组与对照组治疗后血脂、血液流变学指标 (红细胞压积除外 )有显著性差别 (p <0 0 5 ,p <0 0 1,p <0 0 5 )。结论 :中西医结合治疗糖尿病肾病优于单纯西药治疗     

Clinical Study on Endometrial Ovarian Cyst Treated by Combined Laparoscopy and Chinese Herbal Medicine

Ｅｎｄｏｍｅｔｒｉｏｓｉｓｉｓｏｎｅｏｆｔｈｅｃｏｍｍｏｎｒｅ ｆｒａｃｔｏｒｙｄｉｓｅａｓｅｓ，ｗｈｏｓｅｉｎｃｉｄｅｎｃｅｈａｓｂｅｅｎｇｏｉｎｇｕｐａｎｄｒｅａｃｈｅｄ 1 0 % - 1 5%ａｍｏｎｇｃｈｉｌｄ ｂｅａｒｉｎｇｗｏｍｅｎａｃｃｏｒｄｉｎｇｔｏｒ     

中西医结合治疗71例乳腺癌术后患者的疗效分析

目的 研究乳腺癌术后中西医结合治疗疗效。方法 对71例乳腺癌术后患者予以化疗、放疗、内分泌治疗，配合中药治疗。结果 全组均存活，57例术后即以中西医结合治疗，复发2例(3．5％)，转移6例(10．5％)，此8例的中位无病生存期5．9年；另14例术后仅以西医治疗，复发、转移后方开始中药治疗，中位无病生存期3．5年。两者有显著性差异(P=0．033)。结论 中医药能预防、延缓乳腺癌术后的复发、转移。     

中西医结合治疗颅脑外伤后头痛研究

目的 探讨中西医结合治疗颅脑外伤后头痛患的临床疗效。方法550例患按辨证分型分为四型：瘀血型、肝阳上亢型、心阳虚型、肾虚型，分别给予不同的中药治疗及常规西药治疗。46例患只给予单纯西药治疗作为对照组。结果中西医结合治疗组的疗效明显优于对照组。结论中西医结合治疗较单纯西医治疗颅脑外伤后头痛具有明显优势。     

中西医结合治疗一氧化碳中毒迟发性脑病27例

目的 探讨中西医结合治疗一氧化碳中毒迟发性脑病的方法与疗效。方法 将52例一氧化碳中毒迟发性脑病患者随机分成中西医结合治疗组27例和单纯西医对照组25例。中西医结合治疗组在西医治疗的基础上,采用中药清醒合剂和中医针灸治疗。2～5个疗程后,对2组疗效进行比较观察。结果 中西医结合治疗组总有效率为96.3％,单纯西医对照组为84.0％。经Ridit分析处理,2组总有效率有显著性差异(P<0.05)。结论 中西医结合治疗一氧化碳中毒迟发性脑病疗效较好。     

Chinese Medicine Herbal Treatment Based on Syndrome Differentiation Improves the Overall Survival of Patients with Unresectable Hepatocellular Carcinoma

Objective:To investigate the effects of Chinese medicine(CM) herbal treatment based on syndrome differentiation on patients with unresectable hepatocellular carcinoma(HCC).Methods:A total of 94 patients with unresectable HCC were reviewed between June 2008 and June 2011.Survival analysis was performed between patients who received CM with/without non-curative antitumor treatments of Western medicine(WM)(CM group,30cases) and patients who were not treated with CM but with non-curative antitumor treatments of WM or supportive treatment alone(non-CM group,64 cases).Then,survival analysis was performed between patients treated with CM combined with non-curative antitumor treatments of WM(combination therapy group,25 cases) and patients with non-curative antitumor treatments of WM alone(non-curative antitumor treatments group of WM,52 cases).The survival analysis was performed by Kaplan-Meier method and prognostic factors for overall survival(OS) were assessed by the Cox proportional hazards regression model.Results:The median survival time(MST),1- and 2-year survival rates of the CM group and the non-CM group were 36 months,76.7%,56.1%and 12 months,48.4%,26.6%,respectively.The Log-rank test revealed significant difference between the two groups in OS(P<0.01).Cox proportional multivariate analysis revealed that CM was an independent favorable prognostic factor for OS.The MST,1- and 2-year survival rates of combination therapy group and non-curative antitumor treatments group of WM were 36 months,76.0%,55.5%and 13 months,55.8%,30.8%,respectively.There was significant difference in OS between the two groups(P=0.004).Conclusions:CM herbs based on syndrome differentiation have positive effects on survival of patients with unresectable HCC.Furthermore,combination therapy of CM and WM are recommended in HCC treatment.